Skip to content

Clinical effect evaluation and mechanism discussion of bupleurum xuanfuhua decoction in intervention of hashimoto thyroiditis

Clinical effect evaluation and mechanism discussion of bupleurum xuanfuhua decoction in intervention of hashimoto thyroiditis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003971
Enrollment
Unknown
Registered
2020-09-23
Start date
2020-10-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's thyroiditis

Interventions

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnostic criteria of Hashimoto's thyroiditis with hypothyroidism(including subclinical hypothyroidism), TCM syndrome differentiation is liver spleen deficiency, phlegm and blood stasis type; 2. Adult patients aged 18 to 65 years; 3. Signing informed consent.

Exclusion criteria

Exclusion criteria: 1. A history of malignant tumors of the thyroid gland; 2. Patients with severe heart, liver, kidney, blood system diseases or severe mental illness; 3. Pregnant or lactating women; 4. Those who are allergic to drugs; 5. Patients with hyperthyroidism.

Design outcomes

Primary

MeasureTime frame
Foxp3, ROR?t;TG-Ab, TPO-Ab;Depression and anxiety assessment;Thyroid volume and isthmus thickness;QOL;Treg/Th17;TCM symptoms and physical signs;TT3, TT4, FT3, FT4, TSH;TGF-ß, IFN-?, IL-2, IL-6, IL-10, IL-17, IL-23;

Secondary

MeasureTime frame
body weight;memory;fasting plasma glucose;blood lipoid;glycosylated hemoglobin;

Countries

China

Contacts

Public ContactShiwei Liu

Wangjing Hospital, China Academy of Chinese Medical Sciences

liushiwei1977@126.com+86 13810753021

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026